Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy
- 1 November 1996
- journal article
- Published by Elsevier in Molecular Medicine Today
- Vol. 2 (11) , 468-475
- https://doi.org/10.1016/1357-4310(96)10044-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment [see comments]Blood, 1992
- Central role of tumour necrosis factor, GM‐CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemiaBritish Journal of Haematology, 1992
- Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitorsBlood, 1991
- Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3.Journal of Clinical Investigation, 1991
- Juvenile Chronic Myelogenous LeukemiaJournal of Pediatric Hematology/Oncology, 1990
- Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.Journal of Clinical Investigation, 1988
- Juvenile chronic myelogenous leukemia: characterization of the disease using cell culturesBlood, 1986
- Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factorsCancer, 1984
- Persistent epstein-barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studiesBlood, 1983
- Bone-Marrow Responses in Polycythemia VeraNew England Journal of Medicine, 1974